This inventor holds 1 USPTO granted patent. Top assignee: Bcm Developement Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Abdelilah Benosman: Innovator in Cancer Treatment
Introduction
Abdelilah Benosman is a notable inventor based in Sainte-Foy, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and development of new pharmaceutical compounds. His work focuses on enhancing the efficacy of existing cancer therapies.
Latest Patents
Abdelilah Benosman holds a patent for "Derivatives of paclitaxel, method for producing same and uses thereof." This invention relates to new paclitaxel derivatives that demonstrate comparable cytotoxicity to the parent compound. The derivatives are designed for use in drug targeting therapy, providing a promising avenue for cancer treatment. The patent emphasizes the composition and application of these derivatives, as well as their conjugates for treating cancer.
Career Highlights
Benosman is associated with Bcm Development Inc., where he continues to advance his research in pharmaceutical innovations. His work has the potential to significantly impact cancer therapies, offering new hope for patients.
Collaborations
He has collaborated with notable colleagues, including Michel Pagé and Cyrille Bicamumpaka, to further enhance the development of his inventions.
Conclusion
Abdelilah Benosman is a dedicated inventor whose work in developing paclitaxel derivatives showcases his commitment to improving cancer treatment options. His contributions to the field are invaluable and reflect the ongoing need for innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile